Effect of Polymorphisms of VKORC1 and CYP2C9 on Warfarin Dosage in Patients with Atrial Fibrillation

YANG Li,HAN Ming-hua
2012-01-01
Abstract:Warfarin is widely used to control thromboembolism in patients with atrial fibrillation which is the most effective oral anticoagulant utilized so far.It has a narrow therapeutic range but a large individual variation and the curative effect is influenced by many factors,which may lead to insufficient curative effect or bleeding,or even fatal bleeding.The rational and safe use of warfarin has become a key problem in clinical practice.The efficacy of warfarin is affected by many factors,and the genetic polymorphism of hereditary factors is prominent.Here is to make a review on the effects of genetic polymorphisms,such as cytochrome P4502C9 and vitamin K epoxide reducetase,on drug response and therapeutic efficacy of warfarin for patients with atrial fibrillation
What problem does this paper attempt to address?